ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Retinal Changes in Systemic Darbepoetin Alpha Treatment in Patients With Diabetes Mellitus (EPOinDR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00704652
Recruitment Status : Terminated (Patient recruitment was not sufficient to achieve the needed patient numbers.)
First Posted : June 25, 2008
Last Update Posted : April 7, 2015
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
Gabor Deak, Medical University of Vienna

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2009
  Actual Study Completion Date : September 2009